Insulet, DexCom team up for diabetes technology:
This article was originally published in Clinica
Insulin pump manufacturer Insulet has combined with DexCom, a specialist in making glucose monitoring systems, in order to integrate the latter's technology into Insulet's handheld OmniPod system personal diabetes manager (PDM). The non-exclusive agreement sees San Diego, California-based DexCom provide Insulet with access to its continuous glucose monitoring technology, which when incorporated into the PDM, will allow diabetic patients to access real-time glucose values and receive alarms concerning high or low glucose levels. The two companies will develop the product over 2008, with product launch expected in mid-2009.
You may also be interested in...
The AAM has cited multiple reasons for the failure of Medicare Part D to get new generics to its patients, forcing up their costs. The association has offered a list of suggestions to “ensure that first generics are covered at launch, with lower cost-sharing.”
The US FDA is updating its labeling guidance on laparoscopic power morcellation to reflect new evidence showing the treatment may pose a higher cancer risk in older women, as well as to add discussion of containment systems.
Rutgers University professor testifies in support of bill directing the FDA to designate National Centers of Excellence in Continuous Manufacturing; other bills target generic labeling, orphan exclusivity and counterfeit devices.